1. Home
  2. AMH vs CYTK Comparison

AMH vs CYTK Comparison

Compare AMH & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Homes 4 Rent of Beneficial Interest

AMH

American Homes 4 Rent of Beneficial Interest

HOLD

Current Price

$33.23

Market Cap

11.6B

Sector

Real Estate

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$71.44

Market Cap

10.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMH
CYTK
Founded
2012
1997
Country
United States
United States
Employees
1598
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.6B
10.4B
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
AMH
CYTK
Price
$33.23
$71.44
Analyst Decision
Hold
Strong Buy
Analyst Count
19
19
Target Price
$34.92
$89.26
AVG Volume (30 Days)
3.1M
2.2M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
4.22%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$13,368,000.00
Revenue This Year
$2.69
$7.37
Revenue Next Year
$2.26
$310.19
P/E Ratio
$26.59
N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.22
$31.99
52 Week High
$37.10
$80.20

Technical Indicators

Market Signals
Indicator
AMH
CYTK
Relative Strength Index (RSI) 69.12 44.93
Support Level $32.05 $59.07
Resistance Level $33.49 $79.66
Average True Range (ATR) 0.60 2.49
MACD 0.05 -1.11
Stochastic Oscillator 95.53 8.04

Price Performance

Historical Comparison
AMH
CYTK

About AMH American Homes 4 Rent of Beneficial Interest

American Homes 4 Rent is a real estate investment trust focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's geographical markets include Dallas, Texas; Indianapolis, Indiana; Atlanta, Georgia; and Charlotte, North Carolina in terms of the number of properties in each.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: